undefined

Posaconazole-ibrutinib interaction cannot be avoided by staggered dosing: Hoe to optimize ibrtinib dose during posaconazole treatment

Year of publication

2023

Authors

Olkkola AM; Tapaninen T; Tornio A; Hauta-aho M; Lapatto-Reiniluoto O; Neuvonen M; Kiiski JI; Neuvonen PJ; Niemi M; Backman JT

Organizations and authors

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

​Publication forum

52704

​Publication forum level

3

Open access

Open access in the publisher’s service

No

Self-archived

No

Other information

Fields of science

Biomedicine

Internationality of the publisher

Domestic

International co-publication

No

Co-publication with a company

No

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes